Delivery Order SPE2DB20D3101-SPE2DB23FRVU6

Award Date 8/24/23
Potential Completion Date 8/25/23
Potential Value $170
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $3,218.90 delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir tablets. The firm fixed price order is for 30 units of the HIV medication and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 9, 2023 to support DLA programs. No set aside designation or subcontractors were identified. The order was placed under an existing DLA pharmaceutical supply vehicle to...
The Defense Logistics Agency awarded a $3,660.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300 milligram doses of emtricitabine-tenofovir combination medication in 30-count unit packages. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period concluding on September 1, 2023. No additional details were provided regarding the original solicitation requirements or whether this delivery order...
The Defense Logistics Agency awarded a $4,151.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir tablets. The delivery order was issued under an existing prime vendor contract vehicle and calls for the delivery of a 30-day supply of the HIV medication to a Defense Logistics Agency location in Conshohocken, Pennsylvania by September 15, 2023. Amerisourcebergen will perform as the prime contractor, with no mention of major...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $932 to Amerisourcebergen Drug Corporation for 200-300mg doses of the antiretroviral medication emtricitabine-tenofovir. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in September 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for HIV prevention medication is consistent with the...
The Defense Logistics Agency Troop Support Medical awarded a $57,740 delivery order to Amerisourcebergen Drug Corporation for 200-300mg doses of Emtricitabine-Tenofovir, a fixed-dose combination medication used to treat HIV, to be delivered by June 29, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order was placed against an existing Amerisourcebergen Federal Supply Schedule contract with the U.S. Department of Veterans Affairs for pharmaceutical...
The Defense Logistics Agency awarded a $29,314.59 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200-300mg doses of the antiretroviral medication emtricitabine-tenofovir. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on August 25, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor. This delivery...
The Defense Logistics Agency awarded a $692.76 delivery order to Amerisourcebergen Drug Corporation for the provision of 200-300mg emtricitabine-tenofovir combination tablets. The firm fixed price order calls for the delivery of 30 units of the HIV treatment medication to a location in Conshohocken, Pennsylvania, with performance required between July 17-18, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $650 under a Defense Logistics Agency contract to supply 200-300mg doses of the antiretroviral medication emtricitabine-tenofovir. Performance will take place in Conshohocken, Pennsylvania over a one-day period beginning on August 8, 2023. The firm fixed price contract was awarded without any set aside designations. As the DLA supports military readiness...
The Defense Logistics Agency awarded a delivery order valued at $225.72 to Amerisourcebergen Drug Corp for the supply of 200-300mg Emtricitabine-Tenofovir tablets. As the prime contractor, Amerisourcebergen Drug Corp will provide approximately 30 tablets of the HIV medication to meet requirements under the Agency's pharmaceutical supply chain program. The single delivery is to be made to Amerisourcebergen's distribution center in Conshohocken, Pennsylvania within the one-day period of...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,220 to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir tablets. The order, placed under an existing prime vendor contract vehicle, calls for the delivery of 30 bottles of the HIV/AIDS medication to a facility in Conshohocken, Pennsylvania by August 8, 2023 to support the Agency's medical readiness mission. Amerisourcebergen Corporation will perform as the...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRVU6
    Delivery Order

The Defense Logistics Agency awarded a $169.74 delivery order contract to Amerisourcebergen Drug Corporation to supply 200-300mg doses of emtricitabine-tenofovir, a fixed-dose combination medication used to treat HIV, for delivery by August 25, 2023. As the prime contractor, Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. This firm fixed price order is part of DLA's portfolio of contracts to support the medical readiness of military personnel through reliable access to prescription medications and medical supplies.

Generated 12/22/23, 5:15 PM